Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane versus propofol for renal protection after cardiopulmonary bypass heart surgery
ChiCTR1800019481Phase 4Recruiting
- Sponsor
- Affiliated Hospital of Guizhou Medical University
- Start
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of sevoflurane and propofol in acute kidney failure (AKF) (2 arms), sponsored by Affiliated Hospital of Guizhou Medical University. Primary endpoints: neutrophil gelatinase-associated lipocalin and plasma heparan sulfate. Started Nov 2018; status: recruiting.
02
Drugs
sevofluranepropofol
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on ChiCTR1800019481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800019481.